USANA Health Sciences (NYSE:USNA) Hits New 12-Month Low at $42.51

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $42.51 and last traded at $42.55, with a volume of 6757 shares traded. The stock had previously closed at $42.98.

Wall Street Analyst Weigh In

A number of brokerages recently commented on USNA. DA Davidson decreased their target price on USANA Health Sciences from $53.00 to $48.00 and set a “neutral” rating for the company in a research report on Thursday, February 22nd. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th.

USANA Health Sciences Stock Up 9.7 %

The firm’s 50-day simple moving average is $46.71 and its 200-day simple moving average is $48.44. The firm has a market capitalization of $876.38 million, a PE ratio of 14.19, a price-to-earnings-growth ratio of 1.27 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.35. The business had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.94%. On average, equities research analysts forecast that USANA Health Sciences, Inc. will post 2.73 earnings per share for the current year.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, COO Walter Noot sold 5,240 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $49.05, for a total value of $257,022.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $49.05, for a total transaction of $257,022.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Kevin Guest sold 11,011 shares of USANA Health Sciences stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $49.00, for a total transaction of $539,539.00. Following the transaction, the chairman now owns 10,491 shares of the company’s stock, valued at $514,059. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 24,807 shares of company stock worth $1,200,791. Company insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On USANA Health Sciences

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of USANA Health Sciences by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock valued at $91,853,000 after acquiring an additional 38,533 shares during the period. Dimensional Fund Advisors LP lifted its stake in USANA Health Sciences by 3.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock worth $36,323,000 after purchasing an additional 21,524 shares in the last quarter. Pacer Advisors Inc. lifted its stake in USANA Health Sciences by 75.7% in the 4th quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock worth $18,083,000 after purchasing an additional 145,373 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in USANA Health Sciences by 4.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 222,423 shares of the company’s stock worth $11,922,000 after purchasing an additional 8,536 shares in the last quarter. Finally, American Century Companies Inc. raised its position in shares of USANA Health Sciences by 2.3% during the 3rd quarter. American Century Companies Inc. now owns 135,996 shares of the company’s stock valued at $7,971,000 after buying an additional 3,028 shares in the last quarter. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.